Advanced Protein Production (APP) is a Contract Development and Manufacturing Organization, CDMO. With over a decade of expertise in establishing and operating GMP-compliant facilities, the director of Advanced Protein Production (APP) possesses unparalleled knowledge and experience in leading a state-of-the-art facility designed for protein expression and purification. By focusing on protein methodology, APP has the capability to produce large volumes of proteins for both research and clinical applications. In addition, our conjugation facilities enable us to offer Antibody-Drug-Conjugates (ADCs) and other protein conjugates, prepared by a team with decades of experience in chemistry, using the impeccable GMP materials that we produce.

For emerging biotechnology firms that are pioneering innovative protein-based therapies, the availability of a readily accessible GMP production facility is indispensable. APP’s presence optimizes the drug development process unlike any other, providing a streamlined and efficient pathway for bringing these novel therapies to market.